Integer Holdings Co. (NYSE:ITGR) Shares Purchased by Corient Private Wealth LLC

Corient Private Wealth LLC boosted its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 6.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,969 shares of the medical equipment provider’s stock after buying an additional 118 shares during the quarter. Corient Private Wealth LLC’s holdings in Integer were worth $261,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its stake in Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock valued at $99,408,000 after purchasing an additional 9,421 shares in the last quarter. Congress Asset Management Co. increased its position in shares of Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock valued at $66,041,000 after buying an additional 9,565 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Integer by 1.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider’s stock valued at $54,146,000 after buying an additional 4,559 shares in the last quarter. Lord Abbett & CO. LLC raised its stake in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock worth $37,716,000 after buying an additional 9,754 shares during the last quarter. Finally, Tributary Capital Management LLC grew its stake in Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock valued at $38,103,000 after acquiring an additional 2,289 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ITGR has been the subject of a number of research reports. Wells Fargo & Company restated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Raymond James started coverage on Integer in a research report on Friday. They set an “outperform” rating and a $145.00 price target for the company. Benchmark upped their price objective on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, February 21st. Finally, KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and a consensus price target of $148.56.

Integer Price Performance

Shares of NYSE:ITGR opened at $117.94 on Tuesday. The company has a market cap of $3.96 billion, a P/E ratio of 35.10, a P/E/G ratio of 1.72 and a beta of 1.24. The business has a fifty day simple moving average of $130.01 and a 200-day simple moving average of $132.03. Integer Holdings Co. has a 52 week low of $107.11 and a 52 week high of $146.36. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Equities research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.